Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma
Authors: S. Saesoo
S. Sathornsumetee
P. Anekwiang
C. Treetidnipa
P. Thuwajit
S. Bunthot
W. Maneeprakorn
L. Maurizi
H. Hofmann
Ruktanonchai Uracha Rungsardthong
N. Saengkrit
Université Bourgogne Franche-Comté
Swiss Federal Institute of Technology EPFL, Lausanne
Faculty of Medicine, Siriraj Hospital, Mahidol University
Thailand National Science and Technology Development Agency
Keywords: Biochemistry, Genetics and Molecular Biology;Chemical Engineering;Chemistry;Physics and Astronomy
Issue Date: 1-Jan-2018
Citation: Colloids and Surfaces B: Biointerfaces. Vol.161, (2018), 497-507
Abstract: © 2017 Elsevier B.V. Despite advances in neuroscience cancer research during the past decades, the survival of cancer patients has only marginally improved and the cure remains unlikely. The blood-brain barrier (BBB) is a major obstacle protecting the entry of therapeutic agents to central nervous system, especially for primary central nervous system lymphoma (PCNSL). Thus, the use of small nanoparticle as a drug carrier may be new strategies to overcome this problem. In this study, we fabricated liposome consisting of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with anti-CD20 (Rituximab; RTX). The designed nanoparticles have a theranostic property which is not only to improve drug delivery, but also to offer diagnostic and monitoring capabilities. TEM images revealed the spherical shape of liposome with the approximately average diameters about 140–190 nm with slightly negatively charge surfaces. Superparamagnetic property of SPIONs-loaded liposomes was confirmed by VSM. Liposome colloidal could be prolonged at 4 °C and 25 °C storages. RTX conjugated liposome induced cell internalization and apoptosis effect in B-lymphoma cells. Drug targeting and therapeutic effect was investigated in BBB model. The result confirmed that liposome nanocarrier is required as a drug carrier for effectively RTX across the BBB.
ISSN: 18734367
Appears in Collections:Scopus 2018

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.